Key facts
- Liquid Mine’s last known valuation is $2.8M (Feb 2023).
- It has raised $1.2M; the latest was Later Stage VC in May 2025.
- Notable investors include Plug and Play Tech Center, Incubate Fund, Intellectual Property Acceleration Program for Startups, 1stRound, Gemseki — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Liquid Mine
- ·The full record, as it builds
Funding rounds
No funding rounds for Liquid Mine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Liquid Mine
Developer of a monitoring test system designed to be used for early detection of leukemia recurrence. The company's system engages in the development and sales of various medical examination programs, outsourcing of genetic analysis testing, a consignment of pathological examination work, research, development, manufacturing, and sales of in-vitro diagnostics, enabling businesses to get an optimal treatment environment for every cancer patient through genetic analysis.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Employees
- 7
- Website
- liquidmine.co.jp/
- Ownership
- Privately Held (backing)
Liquid Mine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liquid Mine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liquid Mine in its N-PORT filings yet. We sweep new filings monthly.